ArticleJournal of translational medicine2017

Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL.

Yuan Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.